TCM
XENT

Timpani Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Timpani Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-116,690
Closed -$3.34M – 114
2015
Q2 		$3.34M Buy
+116,690
New +$3.06M 0.97% 49

Other funds holding XENT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Timpani Capital Management's XENT Position: Q3 2015 in Review

Timpani Capital Management sold out of Intersect ENT, Inc (XENT) in Q3 2015, closing a stake of 116,690 shares — an estimated $3.34M sold.

Timpani Capital Management first reported a position in XENT in Q2 2015 and held it in 1 quarter. The position peaked at $3.34M in Q2 2015. 125 funds tracked by Wall St. Rank hold XENT as of Q3 2015.

  • Timpani Capital Management reported no remaining Intersect ENT, Inc position as of Q3 2015 after selling out during the quarter.
  • Timpani Capital Management sold 116,690 Intersect ENT, Inc shares in Q3 2015, an estimated $3.34M.
  • Timpani Capital Management first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 1 quarter.
  • Timpani Capital Management's Intersect ENT, Inc position peaked at $3.34M in Q2 2015.
  • 125 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2015.

Based on Timpani Capital Management's 13F filing for Q3 2015, filed 6 Nov 2015.